Clinical trial
Study of Pharmacotherapy of Psychotic Depression
NCT00056472 · Weill Medical College of Cornell University, Other · Completed
Key facts
| NCT number | NCT00056472 |
|---|---|
| Title | Study of Pharmacotherapy of Psychotic Depression |
| Official title | Effectiveness of Selective Serotonin Reuptake Inhibitors Combined With Antipsychotic Medication for the Treatment of Psychotic Depression |
| Acronym | STOP-PD |
| Lead sponsor | Weill Medical College of Cornell University, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder With Psychotic Features |
| Intervention type | Drug, Other |
| Interventions | Olanzapine, Sertraline, placebo |
| Enrollment | 259 |
| Start date | Jan 1, 2003 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Mar 17, 2003 |
| Last update posted | Aug 2, 2013 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: